Sponsored Content

New Symrise CEO Parisot

18 Feb 2025

New Symrise CEO Parisot looks optimistic into 2024 at the Annual General Meeting

– Dr. Jean-Yves Parisot welcomes shareholders to the townhall Holzminden for the first time in his new role 

– CEO presents stable financial figures for past financial year 

– Holzminden-based Group closes first quarter of 2024 with very good sales growth

Symrise held its Annual General Meeting on May 15, 2024. For the first time this took place with the new CEO. In his speech, Dr. Jean-Yves Parisot welcomed the nearly 350 shareholders gathered in the townhall of Holzminden for the first time in his new role. He also thanked his predecessor Dr. Heinz-Jürgen Bertram for his many years of service. His following presentation featured an overview of the development and strategy of the Holzminden-based Group.

“I feel delighted to speak at the Symrise Annual General Meeting for the first time as the Group’s CEO,” said Dr. Jean-Yves Parisot. “We offer our shareholders good opportunities for successful business development, also amid ongoing global uncertainties. Our diversified portfolio, our high level of innovation and our global positioning contribute significantly to this. Our pioneering role in sustainability represents a further key to our success. We want to continue intensifying our efforts in this area until we have achieved net-zero status at all levels by 2045.”

In his presentation to the nearly 350 shareholders present, the new CEO started with a look at the 2023 fiscal year. The year turned out a successful one also with its geopolitical uncertainties. It produced stable organic sales growth of just under eight percent. Both divisions (Taste, Nutrition & Health as well as Scent & Care) recorded significant growth.

In his outlook for the 2024 fiscal year, Parisot stated that Symrise feels confident that it will be able to continue along this successful course. In the first quarter of 2024, the Group managed to increase sales by just under 11% compared with the first quarter of 2023. Overall, Symrise is aiming for organic growth of between five and seven percent this year. This would place the company at a faster growth rate than its respective market. To increase profitability, the company has also launched an efficiency program worth EUR 50 million.

 

New Symrise CEO Parisot
Image courtesy of Symrise AG

Voting results available online

After the presentation of the business figures, the agenda continued to cover the agenda items up for vote. They included the following topics:

  • Appropriation of the accumulated profit for the 2023 fiscal year
  • Resolution to discharge the members of the Executive and of the Supervisory Board for the 2023 fiscal year
  • Appointment of the financial and other auditors
  • Approval of the Remuneration ReportAmendments to the Articles of Incorporation to enable virtual Annual General Meetings and on the arrangements for the participation of Supervisory Board Members
  • Removal of the existing Authorized Capital and the creation of a new Authorized Capital
  • Removal of the existing authorization to issue bonds and to create a new conditional capital
The shareholders approved all items on the agenda with a large majority. The detailed voting results are available for download at https://www.symrise.com/investors/annual-general-meeting/

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more